Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases

Background and Aims:  Infection with Helicobacter hepaticus has been associated with development of hepatocellular carcinoma and gallstones in animal models. In humans, however, the association of H. hepaticus infection with biliary and pancreatic diseases has not been elucidated. The aim of this st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2010-05, Vol.25 (s1), p.S86-S89
Hauptverfasser: Shimoyama, Tadashi, Takahashi, Ryoki, Abe, Daijiro, Mizuki, Ichiro, Endo, Tetsu, Fukuda, Shinsaku
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S89
container_issue s1
container_start_page S86
container_title Journal of gastroenterology and hepatology
container_volume 25
creator Shimoyama, Tadashi
Takahashi, Ryoki
Abe, Daijiro
Mizuki, Ichiro
Endo, Tetsu
Fukuda, Shinsaku
description Background and Aims:  Infection with Helicobacter hepaticus has been associated with development of hepatocellular carcinoma and gallstones in animal models. In humans, however, the association of H. hepaticus infection with biliary and pancreatic diseases has not been elucidated. The aim of this study was to serologically examine the prevalence of H. hepaticus infection in patients with biliary and pancreatic diseases. Methods:  Serum samples obtained from 55 patients with cholelithiasis, 18 with bile duct or gallbladder cancer and 19 with pancreatic cancer were studied. Sera were obtained from 34 control subjects who underwent endoscopy and were diagnosed as not having peptic ulcers or cancers. Seropositivity of H. hepaticus was examined by western blot analysis using a H. hepaticus‐specific antigen. To validate the specificity, positive sera were also tested after absorption with H. hepaticus whole‐cell sonicate. Serum samples were also tested for the presence of anti‐Helicobacter pylori antibody. Results:  Prevalence of antibody to H. hepaticus‐specific antigen in patients with bile tract cancer was 38.8% and was significantly higher than in control subjects (13.1%, P 
doi_str_mv 10.1111/j.1440-1746.2010.06224.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733973190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733973190</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4364-58c47867657379a489c0a166edffbc6dcc543cf17b5aaaf4e7e5ca1d08754cdb3</originalsourceid><addsrcrecordid>eNqNkE-P0zAQxS0EYkvhKyBfEKcUO_6bAwdUQQsscFhYjpbjjFkXNyl2qm2_PQ4t5YovHs289-z5IYQpWdByXm0WlHNSUcXloialS2Rd88XhAZpdBg_RjGgqqobR5go9yXlDCOFEicfoqiZCS63YDIUbSEMcfgRnI7a9jcccMh48XkMMbmitGyHhO9jZMbh9xqH34MYw9KXCUxP6MeP7MN7hNsRg07GkdGXSuwSTB3chg82Qn6JH3sYMz873HH179_brcl1df1m9X765rhxnkldCO660VFIophrLdeOIpVJC533rZOec4Mx5qlphrfUcFAhnaUe0Etx1LZujl6fcXRp-7SGPZhuygxhtD8M-G8VYowoTUpT6pHRpyDmBN7sUtmUFQ4mZOJuNmXCaCaeZOJs_nM2hWJ-fH9m3W-guxr9gi-DFWWBzQetTARLyP12tS1RZcY5en3T3IcLxvz9gPqzWU1X81ckf8giHi9-mn0YWgMJ8_7wykt7e3shPH82S_QaCEaoG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733973190</pqid></control><display><type>article</type><title>Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Shimoyama, Tadashi ; Takahashi, Ryoki ; Abe, Daijiro ; Mizuki, Ichiro ; Endo, Tetsu ; Fukuda, Shinsaku</creator><creatorcontrib>Shimoyama, Tadashi ; Takahashi, Ryoki ; Abe, Daijiro ; Mizuki, Ichiro ; Endo, Tetsu ; Fukuda, Shinsaku</creatorcontrib><description>Background and Aims:  Infection with Helicobacter hepaticus has been associated with development of hepatocellular carcinoma and gallstones in animal models. In humans, however, the association of H. hepaticus infection with biliary and pancreatic diseases has not been elucidated. The aim of this study was to serologically examine the prevalence of H. hepaticus infection in patients with biliary and pancreatic diseases. Methods:  Serum samples obtained from 55 patients with cholelithiasis, 18 with bile duct or gallbladder cancer and 19 with pancreatic cancer were studied. Sera were obtained from 34 control subjects who underwent endoscopy and were diagnosed as not having peptic ulcers or cancers. Seropositivity of H. hepaticus was examined by western blot analysis using a H. hepaticus‐specific antigen. To validate the specificity, positive sera were also tested after absorption with H. hepaticus whole‐cell sonicate. Serum samples were also tested for the presence of anti‐Helicobacter pylori antibody. Results:  Prevalence of antibody to H. hepaticus‐specific antigen in patients with bile tract cancer was 38.8% and was significantly higher than in control subjects (13.1%, P &lt; 0.05). Prevalence of antibody to H. hepaticus‐specific antigen was 18.2% and 10.5% in patients with cholelithiasis and pancreatic cancer, respectively. Seropositivity for H. pylori was similar in all groups. Detection of the H. hepaticus‐specific band was significantly decreased after the sera were absorbed with H. hepaticus whole‐cell sonicate. Conclusion:  Infection with H. hepaticus might be associated with bile duct cancer. Results obtained from absorbed sera suggested high specificity of the western blot analysis.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/j.1440-1746.2010.06224.x</identifier><identifier>PMID: 20586873</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Aged ; Aged, 80 and over ; Antibodies, Bacterial - blood ; Bile Duct Neoplasms - blood ; Bile Duct Neoplasms - epidemiology ; biliary diseases ; Biliary Tract Diseases - blood ; Biliary Tract Diseases - epidemiology ; Biological and medical sciences ; Biomarkers - blood ; Blotting, Western ; Case-Control Studies ; Chi-Square Distribution ; Cholelithiasis - blood ; Cholelithiasis - epidemiology ; Female ; Gallbladder Neoplasms - blood ; Gallbladder Neoplasms - epidemiology ; Gastroenterology. Liver. Pancreas. Abdomen ; Helicobacter hepaticus ; Helicobacter hepaticus - immunology ; Helicobacter Infections - blood ; Helicobacter Infections - epidemiology ; Helicobacter Infections - microbiology ; Humans ; Japan - epidemiology ; Male ; Medical sciences ; Middle Aged ; Pancreatic Neoplasms - blood ; Pancreatic Neoplasms - epidemiology ; serodiagnosis ; Seroepidemiologic Studies</subject><ispartof>Journal of gastroenterology and hepatology, 2010-05, Vol.25 (s1), p.S86-S89</ispartof><rights>Journal compilation © 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4364-58c47867657379a489c0a166edffbc6dcc543cf17b5aaaf4e7e5ca1d08754cdb3</citedby><cites>FETCH-LOGICAL-c4364-58c47867657379a489c0a166edffbc6dcc543cf17b5aaaf4e7e5ca1d08754cdb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1746.2010.06224.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1746.2010.06224.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,1411,23909,23910,25118,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22806257$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20586873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimoyama, Tadashi</creatorcontrib><creatorcontrib>Takahashi, Ryoki</creatorcontrib><creatorcontrib>Abe, Daijiro</creatorcontrib><creatorcontrib>Mizuki, Ichiro</creatorcontrib><creatorcontrib>Endo, Tetsu</creatorcontrib><creatorcontrib>Fukuda, Shinsaku</creatorcontrib><title>Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aims:  Infection with Helicobacter hepaticus has been associated with development of hepatocellular carcinoma and gallstones in animal models. In humans, however, the association of H. hepaticus infection with biliary and pancreatic diseases has not been elucidated. The aim of this study was to serologically examine the prevalence of H. hepaticus infection in patients with biliary and pancreatic diseases. Methods:  Serum samples obtained from 55 patients with cholelithiasis, 18 with bile duct or gallbladder cancer and 19 with pancreatic cancer were studied. Sera were obtained from 34 control subjects who underwent endoscopy and were diagnosed as not having peptic ulcers or cancers. Seropositivity of H. hepaticus was examined by western blot analysis using a H. hepaticus‐specific antigen. To validate the specificity, positive sera were also tested after absorption with H. hepaticus whole‐cell sonicate. Serum samples were also tested for the presence of anti‐Helicobacter pylori antibody. Results:  Prevalence of antibody to H. hepaticus‐specific antigen in patients with bile tract cancer was 38.8% and was significantly higher than in control subjects (13.1%, P &lt; 0.05). Prevalence of antibody to H. hepaticus‐specific antigen was 18.2% and 10.5% in patients with cholelithiasis and pancreatic cancer, respectively. Seropositivity for H. pylori was similar in all groups. Detection of the H. hepaticus‐specific band was significantly decreased after the sera were absorbed with H. hepaticus whole‐cell sonicate. Conclusion:  Infection with H. hepaticus might be associated with bile duct cancer. Results obtained from absorbed sera suggested high specificity of the western blot analysis.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Bacterial - blood</subject><subject>Bile Duct Neoplasms - blood</subject><subject>Bile Duct Neoplasms - epidemiology</subject><subject>biliary diseases</subject><subject>Biliary Tract Diseases - blood</subject><subject>Biliary Tract Diseases - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blotting, Western</subject><subject>Case-Control Studies</subject><subject>Chi-Square Distribution</subject><subject>Cholelithiasis - blood</subject><subject>Cholelithiasis - epidemiology</subject><subject>Female</subject><subject>Gallbladder Neoplasms - blood</subject><subject>Gallbladder Neoplasms - epidemiology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Helicobacter hepaticus</subject><subject>Helicobacter hepaticus - immunology</subject><subject>Helicobacter Infections - blood</subject><subject>Helicobacter Infections - epidemiology</subject><subject>Helicobacter Infections - microbiology</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pancreatic Neoplasms - blood</subject><subject>Pancreatic Neoplasms - epidemiology</subject><subject>serodiagnosis</subject><subject>Seroepidemiologic Studies</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE-P0zAQxS0EYkvhKyBfEKcUO_6bAwdUQQsscFhYjpbjjFkXNyl2qm2_PQ4t5YovHs289-z5IYQpWdByXm0WlHNSUcXloialS2Rd88XhAZpdBg_RjGgqqobR5go9yXlDCOFEicfoqiZCS63YDIUbSEMcfgRnI7a9jcccMh48XkMMbmitGyHhO9jZMbh9xqH34MYw9KXCUxP6MeP7MN7hNsRg07GkdGXSuwSTB3chg82Qn6JH3sYMz873HH179_brcl1df1m9X765rhxnkldCO660VFIophrLdeOIpVJC533rZOec4Mx5qlphrfUcFAhnaUe0Etx1LZujl6fcXRp-7SGPZhuygxhtD8M-G8VYowoTUpT6pHRpyDmBN7sUtmUFQ4mZOJuNmXCaCaeZOJs_nM2hWJ-fH9m3W-guxr9gi-DFWWBzQetTARLyP12tS1RZcY5en3T3IcLxvz9gPqzWU1X81ckf8giHi9-mn0YWgMJ8_7wykt7e3shPH82S_QaCEaoG</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Shimoyama, Tadashi</creator><creator>Takahashi, Ryoki</creator><creator>Abe, Daijiro</creator><creator>Mizuki, Ichiro</creator><creator>Endo, Tetsu</creator><creator>Fukuda, Shinsaku</creator><general>Blackwell Publishing Asia</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201005</creationdate><title>Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases</title><author>Shimoyama, Tadashi ; Takahashi, Ryoki ; Abe, Daijiro ; Mizuki, Ichiro ; Endo, Tetsu ; Fukuda, Shinsaku</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4364-58c47867657379a489c0a166edffbc6dcc543cf17b5aaaf4e7e5ca1d08754cdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Bacterial - blood</topic><topic>Bile Duct Neoplasms - blood</topic><topic>Bile Duct Neoplasms - epidemiology</topic><topic>biliary diseases</topic><topic>Biliary Tract Diseases - blood</topic><topic>Biliary Tract Diseases - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blotting, Western</topic><topic>Case-Control Studies</topic><topic>Chi-Square Distribution</topic><topic>Cholelithiasis - blood</topic><topic>Cholelithiasis - epidemiology</topic><topic>Female</topic><topic>Gallbladder Neoplasms - blood</topic><topic>Gallbladder Neoplasms - epidemiology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Helicobacter hepaticus</topic><topic>Helicobacter hepaticus - immunology</topic><topic>Helicobacter Infections - blood</topic><topic>Helicobacter Infections - epidemiology</topic><topic>Helicobacter Infections - microbiology</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pancreatic Neoplasms - blood</topic><topic>Pancreatic Neoplasms - epidemiology</topic><topic>serodiagnosis</topic><topic>Seroepidemiologic Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimoyama, Tadashi</creatorcontrib><creatorcontrib>Takahashi, Ryoki</creatorcontrib><creatorcontrib>Abe, Daijiro</creatorcontrib><creatorcontrib>Mizuki, Ichiro</creatorcontrib><creatorcontrib>Endo, Tetsu</creatorcontrib><creatorcontrib>Fukuda, Shinsaku</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimoyama, Tadashi</au><au>Takahashi, Ryoki</au><au>Abe, Daijiro</au><au>Mizuki, Ichiro</au><au>Endo, Tetsu</au><au>Fukuda, Shinsaku</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>25</volume><issue>s1</issue><spage>S86</spage><epage>S89</epage><pages>S86-S89</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aims:  Infection with Helicobacter hepaticus has been associated with development of hepatocellular carcinoma and gallstones in animal models. In humans, however, the association of H. hepaticus infection with biliary and pancreatic diseases has not been elucidated. The aim of this study was to serologically examine the prevalence of H. hepaticus infection in patients with biliary and pancreatic diseases. Methods:  Serum samples obtained from 55 patients with cholelithiasis, 18 with bile duct or gallbladder cancer and 19 with pancreatic cancer were studied. Sera were obtained from 34 control subjects who underwent endoscopy and were diagnosed as not having peptic ulcers or cancers. Seropositivity of H. hepaticus was examined by western blot analysis using a H. hepaticus‐specific antigen. To validate the specificity, positive sera were also tested after absorption with H. hepaticus whole‐cell sonicate. Serum samples were also tested for the presence of anti‐Helicobacter pylori antibody. Results:  Prevalence of antibody to H. hepaticus‐specific antigen in patients with bile tract cancer was 38.8% and was significantly higher than in control subjects (13.1%, P &lt; 0.05). Prevalence of antibody to H. hepaticus‐specific antigen was 18.2% and 10.5% in patients with cholelithiasis and pancreatic cancer, respectively. Seropositivity for H. pylori was similar in all groups. Detection of the H. hepaticus‐specific band was significantly decreased after the sera were absorbed with H. hepaticus whole‐cell sonicate. Conclusion:  Infection with H. hepaticus might be associated with bile duct cancer. Results obtained from absorbed sera suggested high specificity of the western blot analysis.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>20586873</pmid><doi>10.1111/j.1440-1746.2010.06224.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0815-9319
ispartof Journal of gastroenterology and hepatology, 2010-05, Vol.25 (s1), p.S86-S89
issn 0815-9319
1440-1746
language eng
recordid cdi_proquest_miscellaneous_733973190
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Antibodies, Bacterial - blood
Bile Duct Neoplasms - blood
Bile Duct Neoplasms - epidemiology
biliary diseases
Biliary Tract Diseases - blood
Biliary Tract Diseases - epidemiology
Biological and medical sciences
Biomarkers - blood
Blotting, Western
Case-Control Studies
Chi-Square Distribution
Cholelithiasis - blood
Cholelithiasis - epidemiology
Female
Gallbladder Neoplasms - blood
Gallbladder Neoplasms - epidemiology
Gastroenterology. Liver. Pancreas. Abdomen
Helicobacter hepaticus
Helicobacter hepaticus - immunology
Helicobacter Infections - blood
Helicobacter Infections - epidemiology
Helicobacter Infections - microbiology
Humans
Japan - epidemiology
Male
Medical sciences
Middle Aged
Pancreatic Neoplasms - blood
Pancreatic Neoplasms - epidemiology
serodiagnosis
Seroepidemiologic Studies
title Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A10%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serological%20analysis%20of%20Helicobacter%20hepaticus%20infection%20in%20patients%20with%20biliary%20and%20pancreatic%20diseases&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Shimoyama,%20Tadashi&rft.date=2010-05&rft.volume=25&rft.issue=s1&rft.spage=S86&rft.epage=S89&rft.pages=S86-S89&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/j.1440-1746.2010.06224.x&rft_dat=%3Cproquest_cross%3E733973190%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733973190&rft_id=info:pmid/20586873&rfr_iscdi=true